ClinicalTrials.Veeva

Menu

Observing the Changes of Endocrine and Metabolism in Patients With Thalassemia Major

National Taiwan University logo

National Taiwan University

Status

Unknown

Conditions

Thalassemia Major

Study type

Observational

Funder types

Other

Identifiers

NCT03951818
201903041RINB

Details and patient eligibility

About

Patient with thalassemia major have many endocrine diseases, such as hypopituitarism, hypothyroidism, hypoparathyroidis, osteoporosis, and etc.. These problems may be due to anemia itself or related to iron deposition. This study aimed to investigate the endocrine aspect of thalassemia major patients in Taiwan in order to introduce early intervention or treatment in the future.

Enrollment

100 estimated patients

Sex

All

Ages

20 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Clinical diagnosis of Thalassemia major
  • Patients of 20-85 years old

Exclusion criteria

  • Patients younger than 20 years old.
  • Patients older than 85 years old.
  • Patients who are pregnant

Trial contacts and locations

1

Loading...

Central trial contact

Shyang-Rong Shih, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems